Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Locations


Orders Processing,
Shipping & Receiving,
Warehouse

2 Shaker Rd Suites
B001/B101
Shirley, MA 01464


Production Lab

Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036

Telephone Numbers



Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565

Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C44043-0.1 0.1 mg (0.1 mg/ml) $432 
CD6 Antibody - Anti-CD6 antibody IHC of human tonsil. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 10 ug/ml.  This image was taken for the unconjugated form of this product. Other forms have not been tested.

Monoclonal Mouse anti‑Human CD6 Antibody (clone MEM‑98, FITC) LS‑C44043

Monoclonal Mouse anti‑Human CD6 Antibody (clone MEM‑98, FITC) LS‑C44043

Note: This antibody replaces LS-C57542, LS-C3946
Antibody:
CD6 Mouse anti-Human Monoclonal (FITC) (MEM-98) Antibody
Application:
Flo
Reactivity:
Human
Format:
FITC, Unmodified
Other formats:
Price
Catalog Number
$432
LS-C44043-0.1
Toll Free North America
206-374-1102
For Research Use Only

Overview

Antibody:
CD6 Mouse anti-Human Monoclonal (FITC) (MEM-98) Antibody
Application:
Flo
Reactivity:
Human
Format:
FITC, Unmodified
Other formats:

Specifications

Description
CD6 antibody LS-C44043 is an FITC-conjugated mouse monoclonal antibody to human CD6. Validated for Flow.
Target
Human CD6
Synonyms
CD6 | CD6 molecule | T12 | TP120 | CD6 antigen
Host
Mouse
Reactivity
Human (tested or 100% immunogen sequence identity)
Clonality
IgG1 Monoclonal
Clone
MEM-98
Conjugations
FITC. Also available Unconjugated.
Purification
Protein G purified
Modifications
Unmodified
Immunogen
Purified CD6 antigen.
Specificity
Recognizes human CD6, also known as T12 or TP120. CD6 is a ~100-130 kD type 1 single pass trans-membrane protein member of the immunoglobulin superfamily. CD6 possesses 3 scavenger receptor cysteine rich domains in it's extracellular sequence. The membrane proximal SRCR3 contains the epitope responsible for interaction with CD166, also known as Activated Leukocyte Cell Adhesion Molecule or CD166. Multiple gene transcripts have been detected encoding CD6 in man resulting in the production of a number of CD6 isoforms. Recognizes an external epitope located in the membrane-distal SRCR domain 1 and is expected to recognize all CD6 isoforms so far identified,. CD6 has been implicated as a therapeutic target for a number of autoimmune conditions including Sjogren's syndrome, rheumatoid arthritis and psoriasis.
Applications
  • Flow Cytometry (1:1)
  • Applications tested for the base form of this product only
Usage
The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. Flow Cytometry: Use 10 ul of the suggested working dilution to label 10^6 cells or 100 ul whole blood. Method sheets are available on request.
Presentation
PBS, 0.09% Sodium Azide, 1% BSA
Storage
Store at 4°C or at -20°C. Store undiluted. Avoid freeze-thaw cycles. Protect from light. Microcentrifugation recommended if solution contains precipitate.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About CD6
P30203 NM_006725 NP_006716.3

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 4/25/2024